Authors: KANTERLEWENSOHN L DRICU A WANG M WEJDE J KIESSLING R LARSSON O

Citation: L. Kanterlewensohn et al., EXPRESSION OF THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR AND ITS ANTI-APOPTOTIC EFFECT IN MALIGNANT-MELANOMA - A POTENTIAL THERAPEUTIC TARGET, Melanoma research, 8(5), 1998, pp. 389-397

Authors: HELLSTROMLINDBERG E AHLGREN T BEGUIN Y CARLSSON M CARNESKOG J DAHL IM DYBEDAL I GRIMFORS G KANTERLEWENSOHN L LINDER O LUTHMAN M LOFVENBERG E NILSSONEHLE H SAMUELSSON J TANGEN JM WINQVIST I OBERG G OSTERBORG A OST A

Citation: E. Hellstromlindberg et al., TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES WITH GRANULOCYTE-COLONY-STIMULATING FACTOR PLUS ERYTHROPOIETIN - RESULTS FROM A RANDOMIZEDPHASE-II STUDY AND LONG-TERM FOLLOW-UP OF 71 PATIENTS, Blood, 92(1), 1998, pp. 68-75

Authors: KANTERLEWENSOHN L HEDBLAD MA WEJDE J LARSSON O

Citation: L. Kanterlewensohn et al., IMMUNOHISTOCHEMICAL MARKERS FOR DISTINGUISHING SPITZ NEVI FROM MALIGNANT MELANOMAS, Modern pathology, 10(9), 1997, pp. 917-920

Authors: HELLSTROMLINDBERG E KANTERLEWENSOHN L OST A

Citation: E. Hellstromlindberg et al., MORPHOLOGICAL-CHANGES AND APOPTOSIS IN BONE-MARROW FROM PATIENTS WITHMYELODYSPLASTIC SYNDROMES TREATED WITH GRANULOCYTE-CSF AND ERYTHROPOIETIN, Leukemia research, 21(5), 1997, pp. 415-425

Authors: KANTERLEWENSOHN L HELLSTROMLINDBERG E KOCK Y ELMHORNROSENBORG A OST A

Citation: L. Kanterlewensohn et al., ANALYSIS OF CD34-POSITIVE CELLS IN BONE-MARROW FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID-LEUKEMIA AND IN NORMAL INDIVIDUALS - A COMPARISON BETWEEN FACS ANALYSIS AND IMMUNOHISTOCHEMISTRY, European journal of haematology, 56(3), 1996, pp. 124-129